CAS RN: 142702-31-6
3,3′-Dithiobispropionic Acid Bis-sulfosuccinimidyl Ester Disodium Salt 90%
Product Availability
Choose a grade to view its available package options.
1 package records0 with current stock1 grade group
| Batch No. | Package | Availability | Lead Time | Inquiry |
| Batchno.20250916 |
50mg |
Out of stock |
5-7 business days | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g
- Available purity: >90%
- Inventory rows with stock: 3
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 142702-31-6
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>90% |
3
In Stock
|
Shanghai |
Inquiry |
| 0.25g |
>90% |
3
In Stock
|
Beijing |
Inquiry |
| 1g |
>90% |
3
In Stock
|
Shanghai |
Inquiry |
142702-31-6 / disodium;1-[3-[[3-(2,5-dioxo-3-sulfonatopyrrolidin-1-yl)oxy-3-oxopropyl]disulfanyl]propanoyloxy]-2,5-dioxopyrrolidine-3-sulfonate
Standard CAS: 142702-31-6
Multi CAS: No
Basic Information
CAS
142702-31-6
Multi CAS
No
Molecular Formula
C14H14N2Na2O14S4
Molecular Weight
608.500000
Exact Mass
607.912326
SMILES
C1C(C(=O)N(C1=O)OC(=O)CCSSCCC(=O)ON2C(=O)CC(C2=O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+]
InChI
InChI=1S/C14H16N2O14S4.2Na/c17-9-5-7(33(23,24)25)13(21)15(9)29-11(19)1-3-31-32-4-2-12(20)30-16-10(18)6-8(14(16)22)34(26,27)28;;/h7-8H,1-6H2,(H,23,24,25)(H,26,27,28);;/q;2*+1/p-2
InChIKey
XRWWBWZHHSXBNC-UHFFFAOYSA-L
Computed Properties
Structural Parameters
Heavy atom count
36
Fraction Csp3
0.57
Rotatable bonds
11
H-bond acceptors
16
Molar refractivity
106.24
TPSA
241.76
LogP / Solubility
WLOGP
-8.58
MLOGP
-7.5
XLogP3
-8.58
Consensus LogP
-8.22
Log S (ESOL)
2.52
Class (ESOL)
Highly soluble
Log S (Ali)
1.65
Class (Ali)
Highly soluble
Log S (SILICOS-IT)
2.19
Class (SILICOS-IT)
Highly soluble
ADME
GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-12.53
Drug-likeness / Medicinal Chemistry
Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Brenk alerts
1
Leadlikeness
No
Synthetic Accessibility
5